Cofactor Genomics is a precision-medicine biotechnology company that applies RNA-sequencing and machine learning to build predictive immuno-oncology diagnostics. Its flagship OncoPrism assay is designed to predict which cancer patients will respond to immunotherapy, and the company runs the multi-center PREDAPT clinical trial across more than 24… - View it on GitHub